San Diego’s Quidel, which signaled it would report better-than-expected quarterly results on Sept. 10, isn’t the only San Diego biomedical company to get a.
Read the original here:
Swine Flu Spurs Investor Interest in San Diego Biomedical Firms …
San Diego’s Quidel, which signaled it would report better-than-expected quarterly results on Sept. 10, isn’t the only San Diego biomedical company to get a.
Read the original here:
Swine Flu Spurs Investor Interest in San Diego Biomedical Firms …
Posted on September 21st, 2009 by admin
0